US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Articles published by ADMA Biologics, Inc.

< Previous 1 2 Next >
News headline image
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Addresses Misleading Short-Seller Report
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Statement on Tariffs
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Set to Join S&P SmallCap 600 Index
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
< Previous 1 2 Next >